All articles by Darcy Jimenez
Darcy Jimenez
Darcy Jimenez is a healthcare reporter for Pharmaceutical Technology and Pharma Technology Focus magazine, covering drug research, development, production and regulation. She is particularly interested in stories about AI, antibiotic resistance, and global health equality.
Sanofi and GSK to seek approval for delayed Covid-19 vaccine
The companies have reported positive study results after a series of delays to the Sanofi-GSK vaccine’s development.
Moderna eyes combined Covid-19, flu booster by 2023
Moderna CEO Stéphane Bancel also said an Omicron-specific Covid-19 vaccine will enter clinical development in a matter of weeks.
UK grants world-first approval to Covid-19 pill molnupiravir
Molnupiravir is the first oral antiviral medication to be approved for the treatment of Covid-19.
Molnupiravir: long-term safety questions linger as approvals approach
Some experts have concerns about the safety of Merck’s investigational Covid-19 antiviral molnupiravir.
4D Pharma Q&A: the potential of gut bacteria in cancer and beyond
4D Pharma CEO Duncan Peyton discusses the company’s work on bacteria-based therapies for cancer, neurodegeneration and more.
Clover Biopharmaceuticals’ Covid-19 jab could help boost global vaccine supply
The clinical-stage company has announced that its Covid-19 vaccine candidate, SCB-2019, is 67% effective against the virus.
ExeVir Q&A: the llama-derived antibody that could fight Covid-19
The company’s lead antibody, XVR011, is currently being trialled in healthy individuals and hospitalised Covid-19 patients.
AZ Covid-19 vaccine scientists commence Phase I trial for plague jab
The jab is based on the same viral vector used in the AstraZeneca coronavirus vaccine.
A century-old tuberculosis vaccine could help fight Covid-19 in the elderly
The Bacillus Calmette-Guérin vaccine is being evaluated against Covid-19 in a number of studies worldwide.
Nothing to sneeze at: nasal sprays to tackle Covid-19
Pharmaceutical Technology takes a look at some of the nasal sprays in development for the treatment and prevention of Covid-19.